Annual Working Capital
$202.88 M
+$45.59 M+28.98%
April 30, 2024
Summary
- As of February 24, 2025, KALV annual working capital is $202.88 million, with the most recent change of +$45.59 million (+28.98%) on April 30, 2024.
- During the last 3 years, KALV annual working capital has fallen by -$51.61 million (-20.28%).
- KALV annual working capital is now -20.28% below its all-time high of $254.49 million, reached on April 30, 2021.
Performance
KALV Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$130.10 M
-$39.12 M-23.12%
October 31, 2024
Summary
- As of February 24, 2025, KALV quarterly working capital is $130.10 million, with the most recent change of -$39.12 million (-23.12%) on October 31, 2024.
- Over the past year, KALV quarterly working capital has stayed the same.
- KALV quarterly working capital is now -48.88% below its all-time high of $254.49 million, reached on April 30, 2021.
Performance
KALV Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
KALV Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +29.0% | 0.0% |
| 3 y3 years | -20.3% | 0.0% |
| 5 y5 years | +108.1% | 0.0% |
KALV Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -20.3% | +29.0% | -36.5% | +53.1% |
| 5 y | 5-year | -20.3% | +150.6% | -48.9% | +132.4% |
| alltime | all time | -20.3% | +8195.9% | -48.9% | +2042.7% |
KalVista Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2024 | - | $130.10 M(-23.1%) |
| Jul 2024 | - | $169.22 M(-16.6%) |
| Apr 2024 | $202.88 M(+29.0%) | $202.88 M(+138.8%) |
| Jan 2024 | - | $84.97 M(-23.3%) |
| Oct 2023 | - | $110.86 M(-18.3%) |
| Jul 2023 | - | $135.71 M(-13.7%) |
| Apr 2023 | $157.29 M(-13.6%) | $157.29 M(-12.9%) |
| Jan 2023 | - | $180.53 M(+29.0%) |
| Oct 2022 | - | $139.90 M(-12.9%) |
| Jul 2022 | - | $160.67 M(-11.8%) |
| Apr 2022 | - | $182.07 M(-11.1%) |
| Apr 2022 | $182.07 M(-28.5%) | - |
| Jan 2022 | - | $204.81 M(-8.7%) |
| Oct 2021 | - | $224.36 M(-7.1%) |
| Jul 2021 | - | $241.55 M(-5.1%) |
| Apr 2021 | $254.49 M(+214.3%) | $254.49 M(+354.6%) |
| Jan 2021 | - | $55.99 M(-10.5%) |
| Oct 2020 | - | $62.54 M(-12.9%) |
| Jul 2020 | - | $71.77 M(-11.4%) |
| Apr 2020 | $80.98 M | $80.98 M(-9.3%) |
| Jan 2020 | - | $89.24 M(-8.4%) |
| Oct 2019 | - | $97.42 M(-4.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jul 2019 | - | $101.75 M(+4.4%) |
| Apr 2019 | $97.49 M(+169.6%) | $97.49 M(-7.4%) |
| Jan 2019 | - | $105.24 M(-3.6%) |
| Oct 2018 | - | $109.13 M(+238.1%) |
| Jul 2018 | - | $32.28 M(-10.7%) |
| Apr 2018 | $36.16 M(+16.0%) | $36.16 M(-13.1%) |
| Jan 2018 | - | $41.63 M(+35.9%) |
| Oct 2017 | - | $30.63 M(+16.2%) |
| Jul 2017 | - | $26.36 M(-15.5%) |
| Apr 2017 | $31.18 M(+45.6%) | $31.18 M(-10.3%) |
| Jan 2017 | - | $34.75 M(+2.4%) |
| Sep 2016 | - | $33.92 M(-5.8%) |
| Jun 2016 | - | $36.03 M(-21.0%) |
| Apr 2016 | $21.42 M(-57.7%) | - |
| Mar 2016 | - | $45.61 M(-10.0%) |
| Dec 2015 | $50.67 M(-2122.1%) | $50.67 M(-12.1%) |
| Sep 2015 | - | $57.66 M(-8.2%) |
| Jun 2015 | - | $62.83 M(-1038.2%) |
| Mar 2015 | - | -$6.70 M(+167.2%) |
| Dec 2014 | -$2.51 M(-142.0%) | -$2.51 M(-230.2%) |
| Sep 2014 | - | $1.93 M(-67.7%) |
| Dec 2013 | $5.96 M(+13.4%) | $5.96 M |
| Dec 2012 | $5.26 M | - |
FAQ
- What is KalVista Pharmaceuticals annual working capital?
- What is the all time high annual working capital for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals annual working capital year-on-year change?
- What is KalVista Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals quarterly working capital year-on-year change?
What is KalVista Pharmaceuticals annual working capital?
The current annual working capital of KALV is $202.88 M
What is the all time high annual working capital for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high annual working capital is $254.49 M
What is KalVista Pharmaceuticals annual working capital year-on-year change?
Over the past year, KALV annual working capital has changed by +$45.59 M (+28.98%)
What is KalVista Pharmaceuticals quarterly working capital?
The current quarterly working capital of KALV is $130.10 M
What is the all time high quarterly working capital for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high quarterly working capital is $254.49 M
What is KalVista Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, KALV quarterly working capital has changed by $0.00 (0.00%)